Kindl_2015_Evid.Based.Complement.Alternat.Med_2015_403950

Reference

Title : Antioxidant and Anticholinesterase Potential of Six Thymus Species - Kindl_2015_Evid.Based.Complement.Alternat.Med_2015_403950
Author(s) : Kindl M , Blazekovic B , Bucar F , Vladimir-Knezevic S
Ref : Evid Based Complement Alternat Med , 2015 :403950 , 2015
Abstract :

The present study aimed to evaluate antioxidant and acetylcholinesterase (AChE) inhibitory activities of the ethanolic extracts of six selected Thymus species growing in Croatia (T. longicaulis, T. praecox subsp. polytrichus, T. pulegioides, T. serpyllum subsp. serpyllum, T. striatus, and T. vulgaris). Antioxidant effectiveness was assessed using six different assays, in comparison with rosmarinic acid, luteolin, and reference antioxidants. All tested Thymus extracts possessed DPPH (IC50 = 3-6 mug/mL) and nitric oxide (IC50 = 70-177 mug/mL) free radical scavenging activities, strong reducing properties (IC50 = 11-15 mug/mL), ferrous ion chelating activity (IC50 = 126-389 mug/mL), ability to inhibit lipid peroxidation (IC50 = 34-80 mug/mL), and high total antioxidant capacities (238-294 mg AAE/g). AChE inhibitory activity was examined using Ellman's colorimetric method and all tested extracts showed anti-AChE activity in a dose dependent manner. The values of 10-28%, 23-39%, and 64-86% were obtained for tested concentrations of 0.25, 0.5, and 1 mg/mL, respectively. Additionally, the contents of total hydroxycinnamic derivatives, flavonoids, and tannins in dried plant samples were determined spectrophotometrically. Our results highlighted Thymus species as a rich source of natural antioxidants and AChE inhibitors that could be useful in preventing and treating Alzheimer's disease and other neurodegenerative disorders.

PubMedSearch : Kindl_2015_Evid.Based.Complement.Alternat.Med_2015_403950
PubMedID: 26351513

Related information

Citations formats

Kindl M, Blazekovic B, Bucar F, Vladimir-Knezevic S (2015)
Antioxidant and Anticholinesterase Potential of Six Thymus Species
Evid Based Complement Alternat Med 2015 :403950

Kindl M, Blazekovic B, Bucar F, Vladimir-Knezevic S (2015)
Evid Based Complement Alternat Med 2015 :403950